Search Within

Eytan Moshe Stein

Formats
  1. Meeting Abstract (217)
  2. Journal Article (104)
  3. Review (17)
  4. Research Letter (14)
  5. Editorial (5)
  6. Book Section (3)
  7. Guidelines (2)
  8. Correspondence (1)
  9. Miscellaneous (1)
Groups
  1. Adult Leukemia (364)
  2. Center for Hematologic Malignancies (364)
  3. Department of Medicine (364)
  4. Hematologic Malignancies, Division of (364)
  5. GSK Faculty (92)
  6. Executive Committee, Center for Hematologic Malignancies (87)

More Groups

People
  1. Martin Tallman (116)
  2. Ross Levine (75)
  3. Aaron Goldberg (41)
  4. Jan Bewersdorf (33)
  5. Andriy Derkach (31)
  6. Christopher Famulare (30)

More People

Years
  1. 2025 (14)
  2. 2024 (44)
  3. 2023 (49)
  4. 2022 (34)
  5. 2021 (31)
  6. 2020 (30)

More Years

Publications
  1. Blood (170)
  2. Journal of Clinical Oncology (23)
  3. Clinical Lymphoma, Myeloma and Leukemia (17)
  4. Haematologica (16)
  5. Blood Advances (14)
  6. Leukemia and Lymphoma (12)

More Publications

Publishers
  1. American Society of Hematology (185)
  2. Elsevier Inc. (30)
  3. American Society of Clinical Oncology (27)
  4. Ferrata Storti Foundation (16)
  5. Nature Publishing Group (15)
  6. Taylor & Francis Group (12)

More Publishers

Results (364)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Extramedullary hematopoiesis of the renal pelvis in a patient with myelofibrosis
    Journal Article

    Stanchina, M.; Rosenbaum, E.; Pronko, A. J.; Liu, Y.; Lewis, N.; Yabe, M.; Stein, E.; Taylor, J.
    Journal of Oncology Practice (2019)

    Fulltext@MSK | Save
  • CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
    Research Letter

    Stanchina, M.; Pastore, A.; Devlin, S.; Famulare, C.; Stein, E.; Taylor, J.
    Journal of Hematology & Oncology (2019)

    Fulltext@MSK | Save
  • Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant?
    Review

    Ball, B.; Stein, E. M.
    Haematologica (2019)

    Fulltext@MSK | Save
  • Molecular and cytogenetic characteristics of myeloid malignancies following luminal gastrointestinal cancer
    Journal Article

    Epstein-Peterson, Z. D.; Devlin, S. M.; Stein, E. M.; Klimek, V. M.; Saltz, L. B.; Tallman, M. S.
    Leukemia Research (2019)

    Fulltext@MSK | Save
  • AML: The future is now or was it yesterday?
    Editorial

    Daver, N.; Stein, E.
    Best Practice and Research: Clinical Haematology (2019)

    Fulltext@MSK | Save
  • RAS mutations confer an increased risk for relapse in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B.; Goldberg, A.; Tallman, M.; Stein, E.
    Annals of Hematology (2019)

    Fulltext@MSK | Save
  • Safety and clinical activity of mutant IDH1 inhibitor IVOSIDENIB (IVO; AG-120) in combination with AZACITIDINE (AZA) for newly diagnosed acute myeloid leukemia (ND AML)
    Meeting Abstract

    DiNardo, C.; Stein, A.; Stein, E.; Fathi, A.; Frankfurt, O.; Schuh, A.; DoĢˆhner, H.; Martinelli, G.; Patel, P.; Raffoux, E.; more...
    Annals of Hematology (2019)

    Fulltext@MSK | Save
  • Cost effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in the United States
    Journal Article

    Stein, E.; Xie, J.; Duchesneau, E.; Bhattacharyya, S.; Vudumula, U.; Ndife, B.; Bonifacio, G.; Guerin, A.; Li, N.; Joseph, G.
    PharmacoEconomics (2019)

    Fulltext@MSK | Save
  • Ivosidenib (IVO; AG-120) in mutant IDH1 relapsed/refractory acute myeloid leukemia (R/R AML): Results of a phase 1 study
    Meeting Abstract

    Pollyea, D. A.; Dinardo, C. D.; de Botton, S.; Stein, E.; Roboz, G. J.; Mims, A. S.; Swords, R. T.; Altman, J. K.; Collins, R.; Mannis, G. N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Alterations in serum bilirubin during enasidenib treatment in patients with or without UGT1A1 mutations
    Meeting Abstract

    Fathi, A. T.; Dinardo, C. D.; Kline, I.; Tu, N.; Attar, E. C.; Stein, E. M.; de Botton, S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save